AnalystsThomas ShraderThomas Shrader's Stock Forecasts
AnalystsThomas Shrader
Analyst Ranking
Bottom 8%
#4227 out of 4548 analysts
Average Return
-12.73%
Win Rate
31%11 out of 36
Risk vs Reward
Poor
Good
Thomas Shrader's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Annexon IncANNX | +173.33% | $2.10 | $5.74 | 2023-05-25 - 2024-04-15 | Strong Buy |
Inmune Bio IncINMB | +117.73% | $10.38 | $22.60 | 2020-09-01 - 2021-08-30 | Strong Buy |
Biohaven LtdBHVN | +101.08% | $16.74 | $33.66 | 2022-12-02 - 2023-12-01 | Strong Buy |
Geron CorpGERN | +54.29% | $1.05 | $1.62 | 2020-04-03 - 2021-04-01 | Strong Buy |
Coya Therapeutics IncCOYA | +48.93% | $5.62 | $8.37 | 2023-05-18 - 2024-04-15 | Strong Buy |
Thomas Shrader Analyst Color
Get additional color on Thomas Shrader's coverage of popular stocks
Thomas Shrader's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ovid Therapeutics IncOVID | 1 | Strong Buy | $11.00 | +243.75% | Initiates Coverage On | 4 months ago |
Promis Neurosciences IncPMN | 1 | Strong Buy | $8.00 | +270.37% | Initiates Coverage On | 6 months ago |
Precision Biosciences IncDTIL | 1 | Strong Buy | $60.00 | +359.42% | Maintains | 9 months ago |
Annexon IncANNX | 2 | Strong Buy | $7.00 | +21.95% | Maintains | a year ago |
Coya Therapeutics IncCOYA | 1 | Strong Buy | $15.00 | +79.21% | Initiates Coverage On | a year ago |
Athira Pharma IncATHA | 2 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Bioatla IncBCAB | 3 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Verona Pharma PLCVRNA | 3 | Strong Buy | $31.00 | N/A | Maintains | a year ago |
Alector IncALEC | 1 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Biohaven LtdBHVN | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | a year ago |
Vaxcyte IncPCVX | 1 | Strong Buy | $69.00 | N/A | Initiates Coverage On | a year ago |
Gain Therapeutics IncGANX | 2 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Sqz Biotechnologies CoSQZB | 2 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Acumen Pharmaceuticals IncABOS | 2 | Strong Buy | $22.00 | N/A | Maintains | 2 years ago |
Inmune Bio IncINMB | 2 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Sigilon Therapeutics IncSGTX | 1 | Strong Buy | $182.00 | N/A | Initiates Coverage On | 2 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $51.00 | N/A | Initiates Coverage On | 3 years ago |
Celularity IncCELU | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Oncosec Medical IncONCSQ | 1 | Strong Buy | $220.00 | N/A | Initiates Coverage On | 3 years ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Voyager Therapeutics IncVYGR | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Denali Therapeutics IncDNLI | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
89bio IncETNB | 1 | Strong Buy | $58.00 | N/A | Maintains | 4 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | 4 years ago |
Geron CorpGERN | 1 | Strong Buy | $3.00 | N/A | Maintains | 4 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $840.00 | N/A | Maintains | 5 years ago |
Biogen IncBIIB | 3 | Hold | $346.00 | N/A | Downgrades | 5 years ago |
Momenta Pharmaceuticals IncMNTA | 2 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Kite Pharma IncKITE | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.